Delivery Order SPE2DB24D2003-SPE2DB25FXLA4
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trintellix 20 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $2,747.66, represents a non-competitive set-aside delivery against AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The contract was completed on August 8, 2025, with performance fulfilled at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,183.42 to AmerisourceBergen Drug Corp for Trintellix 5 mg tablets (30-count packages) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trintellix 5 mg tablets (30-count) with a contract ceiling value of $4,978.44. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,807.82. The order is for the supply of Trintellix 20mg tablets for the DLA. The contract has a firm fixed price pricing type and an ultimate completion date of April 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support...
- This is a $4,039.61 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 30-count tablets of the medication Trintellix 10 mg. The award was made on September 13, 2021, with a completion date of September 14, 2021. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trintellix 5 mg tablets, a neurological medication. The contract has a ceiling value of $5,833.39 and a period of performance through April 23, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,442.25, is for the delivery of Trintellix 10 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 28, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a $3,747.43 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trintellix 10 mg tablets. The contract has a completion date of May 2, 2022 and is a firm fixed-price agreement. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as AmerisourceBergen. Both companies are for-profit organizations registered in the System for Award...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,575.48, is for the supply of Trintellix 5 mg tablets and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,803.14 firm fixed-price delivery order is for the supply of TRINTELLIX 10 MG TABLET 30S, a medication used in the treatment of major depressive disorder. The award has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXLA4Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,427.12 for 30 tablets of Trintellix 20 mg on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Trintellix is a psychiatric medication used to treat major depressive disorder, reflecting the breadth of pharmaceutical products supplied through federal medical procurement channels. This delivery order represents a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves critical federal medical supply needs for military and veteran healthcare systems, leveraging its comprehensive IDC vehicle to fulfill individual delivery orders for medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive portfolio of federal contracts demonstrates its capacity to meet competitive procurement requirements and support the Defense Health Agency and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/24/25 |